Sheng Li
Impact in
- Cancer Research top 1%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Molecular Biology top 2%
- Circular RNAs in diseases
- RNA modifications and cancer
- Muscle Physiology and Disorders
Papers in
-
- Cancer-related molecular mechanisms research 23
- MicroRNA in disease regulation 19
- Cancer, Lipids, and Metabolism 12
-
- Ferroptosis and cancer prognosis 18
- Kidney Stones and Urolithiasis Treatments 13
- Co-authors
- Xian‐Tao Zeng (23 shared papers)Chao Zhang (5 shared papers)Yonggang Zhang (2 shared papers)Joey S.W. Kwong (3 shared papers)Liang Du (1 shared paper)Feng Sun (1 shared paper)Yu‐Ming Niu (1 shared paper)A. Richard Whorton (4 shared papers)
- Journals
- Medicine (11 papers)Frontiers in Oncology (9 papers)Scientific Reports (8 papers)Environmental Toxicology (6 papers)PLoS ONE (5 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Sheng Li
381 papers receiving 8.7k citations
Sheng Li's Hit Papers
Peers
Comparison fields: 5 of 191
- Cancer Research 1.0k
- Molecular Biology 2.6k
- Pharmacology 585
- Urology 192
- Pulmonary and Respiratory Medicine 956
Countries citing papers authored by Sheng Li
This map shows the geographic impact of Sheng Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Li more than expected).
Fields of papers citing papers by Sheng Li
This network shows the impact of papers produced by Sheng Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Li. The network helps show where Sheng Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheng Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 403 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The methodological quality assessment tools for preclinical and clinical studies, systematic review and meta‐analysis, and clinical practice guideline: a systematic review Hit paper breakdown → | 2015 | 1653 |
| 2 | 2010 | 402 | |
| 3 | 2013 | 195 | |
| 4 | 2010 | 120 | |
| 5 | 2004 | 111 | |
| 6 | 2023 | 102 | |
| 7 | 2003 | 91 | |
| 8 | 2019 | 91 | |
| 9 | 2021 | 90 | |
| 10 | 2016 | 88 | |
| 11 | 2016 | 85 | |
| 12 | 2015 | 82 | |
| 13 | 2017 | 81 | |
| 14 | 2017 | 80 | |
| 15 | 2002 | 80 | |
| 16 | 2018 | 79 | |
| 17 | 2013 | 78 | |
| 18 | 2005 | 73 | |
| 19 | 2023 | 73 | |
| 20 | 2007 | 71 |
About Sheng Li
Sheng Li is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology, Pharmacology and Oncology, having authored 403 papers that have together received 8.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (23 papers), MicroRNA in disease regulation (19 papers), Circular RNAs in diseases (19 papers), Ferroptosis and cancer prognosis (18 papers), Liver Disease Diagnosis and Treatment (14 papers), Kidney Stones and Urolithiasis Treatments (13 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Cancer, Lipids, and Metabolism (12 papers). The work is most often cited by research in Cancer Research (1.0k citations), Molecular Biology (2.6k citations), Pharmacology (585 citations), Urology (192 citations) and Pulmonary and Respiratory Medicine (956 citations). Sheng Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Xian‐Tao Zeng, Chao Zhang, Yonggang Zhang, Joey S.W. Kwong, Liang Du, Feng Sun, Yu‐Ming Niu, A. Richard Whorton, Lina Zhang and Yangyang Zhang. Their work appears in journals such as Medicine, Frontiers in Oncology, Scientific Reports, Environmental Toxicology and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.